搜索临床试验以:Hsp90 inhibitor
总计67812个结果
-
Esanex Inc.National Cancer Institute (NCI)完全的
-
Sarcoma Alliance for Research through CollaborationUnited States Department of Defense; Synta Pharmaceuticals Corp.完全的
-
Infinity Pharmaceuticals, Inc.终止
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的
-
Memorial Sloan Kettering Cancer CenterNovartis终止
-
Dale Shepard, MD, PhDNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)终止
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.完全的
-
Synta Pharmaceuticals Corp.完全的乳腺癌 | 三阴性乳腺癌 | HER-2阳性乳腺癌 | ER/进行性反应 (PR) + 先前激素治疗难治西班牙, 美国, 阿根廷, 比利时, 巴西, 大韩民国, 秘鲁, 英国
-
David M. Jackman, MDMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Synta Pharmaceuticals Corp.完全的
-
ARCIM Institute Academic Research in Complementary...招聘中
-
Novartis Pharmaceuticals完全的
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom未知
-
Biogen终止
-
Massachusetts General HospitalDana-Farber Cancer Institute; Infinity Pharmaceuticals, Inc.终止
-
Novartis Pharmaceuticals终止
-
Emory UniversitySynta Pharmaceuticals Corp.终止IVA 期口腔鳞状细胞癌 | IVA 期喉鳞状细胞癌 | IVA 期口咽鳞状细胞癌 | I 期下咽鳞状细胞癌 | I期喉鳞状细胞癌 | I期口咽鳞状细胞癌 | II期下咽鳞状细胞癌 | II期喉鳞状细胞癌 | II期口咽鳞状细胞癌 | III 期下咽鳞状细胞癌 | III期喉鳞状细胞癌 | III 期口咽鳞状细胞癌 | IVA 期下咽鳞状细胞癌 | III 期口腔鳞状细胞癌 | I 期口腔鳞状细胞癌 | II期口腔鳞状细胞癌美国
-
Novartis Pharmaceuticals完全的复发或难治性多发性骨髓瘤德国, 西班牙, 新加坡, 美国, 澳大利亚
-
Debiopharm International SASyneos Health终止
-
SCRI Development Innovations, LLCNovartis Pharmaceuticals完全的Metastatic or Unresectable Solid Tumor Malignancy美国
-
Meir Medical Center未知
-
Novartis Pharmaceuticals完全的
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.; Exelixis主动,不招人
-
Novartis Pharmaceuticals完全的
-
H. Lee Moffitt Cancer Center and Research InstituteExelixis完全的